Cannabinoid Receptors

17 Item(s)

per page

Set Descending Direction
  1. UR-144

    Catalog No. A11096
    UR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM). Learn More
  2. AM1241

    Catalog No. A16397
    CB2 receptor agonist
    AM1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor. Learn More
  3. Bay 59-3074

    Catalog No. A16328
    CB1/CB2 receptor agonist
    Bay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively . Learn More
  4. AM630

    Catalog No. A14993
    CB2 antagonist
    AM630 is a selectivity CB2 antagonist with Ki of 31.2 nM, > 150 fold selectivity over CB1 receptor. Learn More
  5. Otenabant

    Catalog No. A15200
    CB1 receptor antagonist
    Otenabant is a recently discovered selective, high affinity, competitive CB1 receptor antagonist with Ki of 0.7 nM. Learn More
  6. PB-22

    Catalog No. A14110
    PB-22 is an analog of JWH 018 which differs by having 8-hydroxyquinoline replacing the naphthalene group of JWH 018. Learn More
  7. Tedalinab

    Catalog No. A14189
    CB2 receptor agonist
    Tedalinab (GRC-10693) is a drug developed for the treatment of osteoarthritis and neuropathic pain, which acts as a potent and selective cannabinoid CB2 receptor agonist. It has a very high selectivity of 4700x for CB2 over the related CB1 receptor, has good oral bioavailability and has shown promising safety results and effective analgesic and antiinflammatory actions in early clinical trials. Learn More
  8. AM 2201

    Catalog No. A14174
    Cannabinoid inhibitor
    AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively Learn More
  9. AM251

    Catalog No. A12914
    CB1 receptor antagonist
    AM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors. Learn More
  10. Org 27569

    Catalog No. A11513
    CB1 modulator‎
    Org 27569 is a potent CB1 receptor allosteric modulator (pEC50 = 8.24). Learn More
  11. Rimonabant (SR141716)

    Catalog No. A11547
    Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane. Learn More
  12. GW842166X

    Catalog No. A11253
    CB2 receptor agonist
    GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain Learn More
  13. CB1 antagonist
    CP 945598 is a potent and highly selective CB1 antagonist. Learn More
  14. MDA 19

    Catalog No. A11939
    CB2 agonist
    MDA 19 is a potent and selective agonist for the cannabinoid receptor CB2, with reasonable selectivity over the psychoactive CB1 receptor. Learn More
  15. BML-190

    Catalog No. A11938
    CB2 receptor ligand
    BML-190 is a selective inverse agonist of the human cannabinoid CB2 receptor. Learn More
  16. WIN 55,212-2 mesylate

    Catalog No. A11932
    CB receptor agonist
    WIN 55,212-2 is a potent cannabinoid receptor agonist that has been found to be a potent analgesic in a rat model of neuropathic pain. It activates p42 and p44 MAP kinase via receptor-mediated signaling. Learn More
  17. Rimonabant hydrochloride

    Catalog No. A11548
    CB1 receptor inverse agonist
    Rimonabant hydrochloride is a CB1 receptor inverse agonist. Learn More

17 Item(s)

per page

Set Descending Direction